The huge former Ben Venue injectables manufacturing plant in Ohio that became the center of controversy over drug shortages a few years ago remains off line, and the company that now owns the site reiterated this week that it has no plans to resume making...
Hikma has bought defunct manufacturer Ben Venue and says it could reactivate the site in the long-term, despite the transfer of equipment across its sterile injectables network.
Higher demand for methadone, buprenorphine and opiates coupled with the positive impact of a recent acquisition drove first half growth at Swiss supplier Siegfried.
US firm SAFC plans to turn its dry powder culture media manufacturing plant in Lenexa, Kansas into a “centre of excellence” with $6.3m (€4.7m) capacity expansion.
India’s Shasun Chemicals officially closed its pharmaceutical manufacturing plant near Annan in Scotland today yesterday, a little under six months after saying that it was ‘underused’ and could not be kept on as a going concern
in-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.
At this week's Informex show in New Orleans, experts at a packed
out session discussed the potential of up-and-coming continuous
processing technologies and posed the question: is batch processing
yesterday's technology?
US firm Aptuit has announced it will invest $100m (€75m) in
India-based Laurus Labs to form a new joint venture - just a few
months after splurging a similar amount to expand its capabilities.
Patheon has received the 2005 Contract Manufacturing Company of the
Year Award from consultancy firm Frost & Sullivan, in
recognition of its customer service and innovative market growth
strategies.
